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A large number of cytokines and growth factors support the
development and subsequent maintenance of postnatal motor
neurons. RegIII, also known as Reg2 in rat and HIP/PAP1 in
humans, is a member of a family of growth factors found in many
areas of the body and previously shown to play an important role
in both the development and regeneration of subsets of motor
neurons. It has been suggested that RegIII expressed by motor
neurons is both an obligatory intermediate in the downstream
signaling of the leukemia inhibitory factor/ciliary neurotrophic
factor (CNTF) family of cytokines, maintaining the integrity of
motor neurons during development, as well as a powerful influ-
ence on Schwann cell growth during regeneration of the periph-
eral nerve. Here we report that in mice with a deletion of the
RegIII gene, motor neuron survival was unaffected up to 28
weeks after birth. However, there was no CNTF-mediated rescue of
neonatal facial motor neurons after axotomy in KO animals when
compared with wild-type. In mice, RegIII positive motor neurons
are concentrated in cranial motor nuclei that are involved in the
patterning of swallowing and suckling. We found that suckling
was impaired in RegIII KO mice and correlated this with a
significant delay in myelination of the hypoglossal nerve. In sum-
mary, we propose that RegIII has an important role to play in the
developmental fine-tuning of neonatal motor behaviors mediating
the response to peripherally derived cytokines and growth factors
and regulating the myelination of motor axons.
Schwann cells  suckling  hypoglossal nerve  LIF
A large number of neurotrophic factors and cytokines havebeen shown to sustain developing motor neurons and to
encourage the survival of postnatal motor neurons after damage
(1–6). Rat Reg2 [also known as RegIII in mouse and HIP/
PAP1 in humans (7)] has been reported to play an important role
in both the support of motor neurons during development and
in the process of axon regeneration through axon–Schwann cell
signaling in the adult peripheral nervous system (8, 9). Reg2 is a
member of a large family of over 17 related genes divided into
four subtypes (types I, II, III, and IV) based on the primary
structures of the encoded proteins of the genes (10–13). Reg2 is
the equivalent of mouse RegIII gene, which share 90% homol-
ogy at both the nucleotide and protein level. First identified as
a transcript up-regulated in pancreatitis, Reg2, a secreted pro-
tein (relative Mr 16,000) found in many sites throughout the
body, was shown to have an anti-apoptotic action on pancreatic
cell lines (14). Reg2 also promotes the growth of epithelial
intestinal cells, whereas loss of Reg2/RegIII delayed liver
regeneration (10, 15–18).
Two roles have been proposed for Reg2 in the nervous system.
First, in vivo studies have suggested that Reg2 is released from
damaged motor and sensory neurons and has a proregenerative
function (9, 19, 20). Secondly, in vitro data have cast Reg2 as a
neurotrophic factor for motor neurons acting as an obligatory
intermediate for the ciliary neurotrophic factor (CNTF)/
leukemia inhibitory factor (LIF) family of cytokines (8). In the
adult rat, Reg2 is massively up-regulated in motor neurons and
some sensory neurons after nerve crush (19) and is rapidly
transported to the lesion site, where it is thought to be secreted
and act on Schwann cells. In vitro, Reg2 has a mitogenic effect
on Schwann cells and inhibition of Reg2 with a neutralizing
antibody retards the progress of regeneration. Taken together,
it seemed likely that the Schwann cell response at the point of
axotomy was potentiated by release of Reg2 from damaged
axons (9).
Here, we describe the effects of targeted ablation of the
RegIII gene in mice and show a developmental role of RegIII
in axon–Schwann cell signaling. We also report that RegIII is
required to promote the response of subsets of motor neurons to
CNTF but not for motor neuron survival.
Results
Generation of RegIII-Deficient Mice. KO mice were homozygous
for a targeted disruption of the RegIII gene locus created in ES
cells, in which a region from exons 2 to 5 was deleted and
replaced by an IRES-Tau-LacZ-loxP/MC1neopA/loxP reporter/
selection cassette, thus resulting in a null allele. Mice homozy-
gous for the RegIII-null allele were phenotypically indistin-
guishable from wild-type or heterozygous littermates. No
embryonic lethality or significant developmental defects were
observed in RegIII/ animals. Adult RegIII/ mice of both
sexes were fertile, and litter size was normal. We compared the
expression of RegIII between wild-type and KO animals by
using quantitative RT-PCR (RT-qPCR) and found that, as
expected, the expression of RegIIImRNA dropped from 100
25.2% (wild type) to 0.08  0.02% (KO) (n  6 per group).
Immunohistochemistry also showed a complete lack of RegIII
protein-like immunoreactivity in postnatal KO mice (Fig. 1). To
check for potential compensatory up-regulation, we also mea-
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sured the expression of RegIII and RegIII: There was no
difference inRegIII expression (100 67% in wild type vs. 62
43% in KO), but we found a substantial elevation of RegIII in
the brainstem of KO mice (100  26% in wild type vs. 667 
181% in KO).
RegIII Labeling of Neuronal Populations Is Restricted and Develop-
mentally Regulated. In wild-type embryos, RegIII proteins are
first detected in subsets of motor neurons at embryonic day
(E)13–E14 in cervical spinal cord, as previously described in rat
(8), with expression peaking at E18.5 (2). Within the brainstem
at postnatal day (P)1–P5, subsets of neurons along the medial
half of the motor nucleus of the trigeminal and in the dorsal and
medial regions of the facial nucleus were immunoreactive for
RegIII (Fig. 2). The heaviest concentrations of RegIII posi-
tive neurons (up to 50% at P1) were found throughout the caudal
half of the hypoglossal nucleus (XII) and nucleus ambiguus
notably at day 1, but staining intensity reached maximal levels by
P4. By P11, RegIII staining had been lost from all areas of the
brain and spinal cord.
Motor Neurons Are Not Lost After RegIII Deletion. Two lines of
evidence imply that motor neuron survival is not compromised
by loss of RegIII. First, in KO mice, -galactosidase staining is
still visible in motor neurons similar in position to those that
show RegIII expression in wild-type mice (Fig. 3). The tau–
lac-Z strategy designed to transport -galactosidase into axons
met with limited success because the reaction product was only
obviously visualized in motor neuron cell bodies and dendrites.
These motor neurons included the spinal motor neurons and
trigeminal, facial, hypoglossal, and nucleus ambiguus motor
neurons up to P10. Postnatally, sacral motor neurons stained
positively for -galactosidase (Fig. 3B), but brainstem expression
was restricted to small foci within the cytoplasm of motor
neurons (Fig. 3C) or the occasional heavily stained motor
neuron (Fig. 3A). In the spinal cord, -galactosidase reaction
product was found in only the medial column of neurons
comparable in position to RegIII immunoreactive neurons
seen in wild-type mice (Fig. 3B). -Galactosidase expression was
not present beyond P10. Second, the total number of motor
neurones in the facial motor nucleus of P5.5–P10.5 mice or mice
24 weeks old were not significantly different between wild-type
and KO mice implying that no motor neuron cell death had
resulted from the loss of RegIII [see supporting information
(SI) Fig. S1].
Lack of Effect of CNTF on Facial Motor Neuron Survival in RegIII KO
Mice. CNTF applied to the cut end of the facial nerve delays the
axotomy provoked death of neonatal rat facial motor neurons
(21). To examine the effects of CNTF in RegIII KO mice, we
cut the facial motor nerve unilaterally at P3.5 and then imme-
diately applied CNTF or saline to the cut end of the nerve. Mice
were then allowed to survive for 3 days. The loss of facial motor
neurons after facial nerve lesion (FNL) was comparable between
wild-type and KOmice (45% and 49% loss when compared with
contralateral side in wild-type and KO, respectively) (Fig. 4).
There was a significant effect of CNTF on wild-type mice when
P5.5 +/+ Mouse
Facial nucleus
P5.5 -/- Mouse
Facial nucleus
A
B
Fig. 1. RegIII immunoreactivity is found in subsets of facial motor neurons
in P5 wild-type mice but was not found in the postnatal KO mouse central
nervous system. (A) Facial motor nucleus (P5) of a wild-type mouse. (B)
Absence of staining in KO facial nucleus. (Scale bar, 120 m.)
A B
C
D
Fig. 2. RegIII immunoreactivity is found in subsets of cranial and spinal
motor nuclei up to P12. (A) Facial motor nucleus with labeled axons (arrow)
streaming into the facial nerve. (B–D) RegIII-positive neurons within the
nucleus ambiguus (B), the hypoglossal nuclei (C), and the motor nucleus of the
trigeminal (D). All specimens were from P5 mice. [Scale bars: 100m (A, B, and
D); 150 m (C).]
A B
C
Fig. 3. -Galactosidase activity is present postnatally in subsets of motor
neurons in the RegIIIKO mouse. (A) Motor neuron in the facial motor nucleus
at P3. (B) Sacral motor neurons at P1. (C) Punctate -galactosidase staining in
the facial motor nucleus at P5. [Scale bars: 20 m (A); 60 m (B); 40 m (C).]
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compared with both CNTF-treated KO and saline-treated wild-
type mice (24% and 32% savings respectively, P  0.001 for
both) (Fig. 4). When mice were allowed to survive for four days
after FNL, cell loss was considerable but CNTF produced
significant savings in the numbers of dying neurons in wild-type
mice when compared with KO mice (Fig. S2).
We have previously shown (9) that section of the sciatic nerve
results in down-regulation of Reg2/RegIII in motor neurons in
rat pups and up-regulation in adult rats. However, in mouse pups
with facial nerve axotomy at P3.5 and perfused 2 days later, we
did not detect any change in numbers of RegIII-positive
neurons in the facial motor nucleus. However, application of
CNTF after facial nerve section at P3.5 in mouse pups signifi-
cantly increased the number of RegIII-positive neurons seen 2
days later to 148% compared with the contralateral side (P 
0.0001) (Fig. 5 and Fig. S3). Finally, whereas in adult rats, Reg2
is expressed by all facial motor neurons within 24h of axotomy,
in adult mice, RegIII is not reexpressed in facial motor neurons
1–7 days after axotomy (Fig. S4).
Loss of RegIII Impairs Suckling Behavior. In newborn mouse pups,
we noted that neurons immunoreactive for RegIII were found
to be concentrated in cranial motor neurons that have been
associated with suckling and swallowing, such as the hypoglossal
nucleus and nucleus ambiguus. We therefore examined the
ability of RegIII KO mice to ingest milk during a 1-h period of
suckling after a 2-h period of isolation from the mother. Com-
pared with wild-type pups, we found a significant reduction in
milk/colostrum ingestion: percentage weight increase in wild-
type mice, 3.1  0.2%; and in KO mice, 0.45  0.2 (P  0.01).
Loss of RegIIIDelays Myelination of the Hypoglossal Nerve.Because
of the influence of Reg2 on Schwann cells (9) and the reduced
efficiency of suckling described above, we used electron micros-
copy to analyze myelination in the hypoglossal nerve at P5 in
wild-type and KO mice. Oculomotor neurons never express
RegIII, and we, therefore, used the P5 oculomotor nerve as a
control. We found a significant increase in the numbers of
unmyelinated nerve fibres in both the medial and lateral hypo-
glossal nerves in KO mice at P5 (Fig. 6 A–C). One-way ANOVA
revealed a significant effect of genotype on axon type in both the
medial (F1,14  24.8; P  0.01) and lateral hypoglossal nerves
(F1,13 21.5; P 0.01) There were no differences in the numbers
of unmyelinated axons in the oculomotor nerves in P5 wild-type
and KOmice. In the lateral hypoglossal nerve, the total numbers
of axons in the RegIII KO mice exceeded that in the wild-type
animals (Fig. 6C). We therefore counted the total number of
myelinated axons in the lateral and medial hypoglossal nerves at
P21. We found that there were no differences between the two
groups (wild type: lateral, 352.3 25.8; medial, 980.3 9.5; KO:
lateral, 360.0  16.5; medial, 950.3  41.9 KO; n  3 in each
group). We concluded that excess collateralization of hypoglos-
sal axons occurs because of delayed myelination during the early
postnatal period in KOmice and is lost later by selective pruning
of excess axonal branches (22, 23).
The impaired suckling phenotype, thus, may result from a
disruption of myelination in mutant mice. We also examined the
hypoglossal innervation of tongue musculature in wild-type and
KO mice by using protein gene product (PGP) as a marker for
nerve fibers and -bungarotoxin for muscle end plates. We
found no evidence of changes in innervation density or size of
muscle end plates (data not shown).
Discussion
Previous research has suggested that in vitro rat Reg2 is a motor
neuron survival factor essential for the actions of CNTF-like
cytokines and a powerful Schwann cell mitogen that potentiates
axonal repair and regeneration in vivo (8, 9). However, we show
here that in mice with a genetic deletion of the RegIII gene (the
equivalent gene to Reg2 in rats), there is no increased motor
neuron cell death during development. Nevertheless, we report
that the efficacy of CNTF in reducing neuronal cell death was
diminished in RegIII KO mice indicating that RegIII is
important for the survival functions of CNTF. Finally, we found
that myelination was delayed in subsets of hypoglossal motor
neurones in KO animals and the efficiency of milk ingestion
reduced.
RegIII Is an Intermediate in the CNTF Survival Pathway. The sug-
gestion that Reg2/RegIII was a motor neuron neurotrophic
factor and a signaling intermediary in the CNTF survival path-
way stems from elegant in vitro studies demonstrating that
purified Reg2 can act as a paracrine/autocrine neurotrophic
factor for a subset of motor neurons (8). Furthermore, it has
been shown that CNTF, as well as the related factors LIF,
cardiotrophin 1, and oncostatin-M, rapidly induces Reg2 mRNA
in some motor neurons and that released Reg2 acts in a
paracrine/autocrine fashion to support motor neurons (8, 9). The
CNTF/LIF family of cytokines signal through a receptor complex
that includes the LIF receptor (LIFR) subunit, and it has been
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Fig. 4. Application of CNTF to the cut facial nerve results in increased survival
of facial motor neurons in wild-type but not KO mice counted 3 days after
nerve section. The data show means  SEM (n  4-5 in each group). **,
P  0.001.
WT
IpsiIpsi Contra Contra
CNTF SalineN
um
be
r 
of
 R
eg
III
 
 p
os
iti
ve
 fa
ci
al
 m
ot
or
 n
eu
ro
ns 450
400
350
300
250
200
150
100
50
0
***
***
A CNTF
Ipsi
B
Saline
Ipsi
C
Fig. 5. CNTF increases the number of RegIII positive neurons. (A) Applica-
tion of CNTF to the cut facial nerve results in increased numbers of RegIII-
positive facial motor neurons in wild-type mice 2 days after nerve section. The
data show means  SEM (n  7 in each group). ***, P  0.0001. (B and C)
RegIII-positive neurons in wild-type mice after facial nerve cut and CNTF (B)
or saline (C) application. The arrow indicates the increased number of RegIII-
positive neurons induced by CNTF. [Scale bar, 150 m (B and C).]
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shown previously that in LIFR KO mice, there is no expression
of Reg2/RegIII during development (9). Thus, Reg2/RegIII
expression in some developing motor (and sensory) neurons
depends on cytokines of the LIF family acting through a receptor
complex containing LIFR.
The absence of motor neuron cell death in KOmice, therefore,
is puzzling, especially given that RegIII is essential for the in
vitro neuronal survival effects of CNTF to be manifest. The
evidence for a lack of effect on motor neuron survival comes
from the presence of -galactosidase reaction product in post-
natal neurons up to P10 and the normal numbers of facial motor
neurons in KO mice. However, in CNTF KO mice, there is
similarly no increased loss of motor neurons during the first
weeks of life (24, 25). This, perhaps, is not surprising, given that
levels of CNTF are low during development and, although
Schwann cells are the richest source of CNTF in the adult
peripheral nervous system, levels only rise during the first
postnatal week (26–28). Knockout of the CNTF gene did result
in motor neuron loss 28 weeks after birth (24); however, RegIII
mice did not show motor neuron loss in later adult stages.
Previous studies suggest that CNTF itself is not the key ligand
acting at the CNTF/LIF receptor complex. Nishimune et al. (8)
found that RegIII expression was unimpaired or delayed in a
range of KOs including cntf, ct1, and cntf/lif double mutants,
leading them to suggest that a factor as yet unknown was key to
driving the expression of RegIII in motor neurons.
That CNTF-like factors are as important in vivo as in vitro and
require ReIII expression is implied by the observation that
RegIII expression increases in axotomized neurons only when
CNTF is applied to the nerve stump and that CNTF has no
survival effect on motor neurons in RegIII KO mice. We also
show that the number of RegIII neurons increased in wild-type
mice when CNTF was applied to the cut nerve. This implies that
many motor neurons have the capacity to express RegIII, but
this number is restricted by availability of CNTF-like factors
during development. Nevertheless, RegIII may not be the only
intermediary involved in CNTF-like factor signaling as only
15–20% of facial motor neurons express RegIII, and CNTF
has previously been shown to rescue 75% of rat facial motor
neurons from cell death when axotomized soon after birth (24).
However, the substantially larger concentration of CNTF used in
these experiments (5 g vs. 250 ng used in the present study) may
well have driven the expression of RegIII in many more
axotomized facial motor neurons than seen here and resulted in
greater levels of survival (24). Also the dynamics of Reg2
expression in rat are different from that of RegIII in mice.
RegIII never reappeared in the adult mouse after section of the
facial nerve (Fig. S4) or sciatic nerve (data not shown) and did
not noticeably decrease 24 h after axotomy, as was observed after
sciatic transection in neonatal rats. Presumably other factors may
play a similar role to RegIII in adult mouse motor neurons,
although it is unlikely to be RegIII, which although up-regulated
in the KO mouse, did not potentiate CNTF-mediated survival.
Growth Factors and Myelination.We show here that myelination of
a subset of hypoglossal motor neuron axons is delayed in RegIII
KO mice at P5.5 but normal by P21. This seems likely to be
attributable to the loss of RegIII because myelination of
oculomotor axons in KOmice was normal and oculomotormotor
neurons did not express RegIII at any stages of development.
This delayed myelination would be expected to disrupt the
transmission of signals along the axon and may account for the
reduced efficiency of suckling behavior. Delayedmyelination did
not, however, result in any reduction in the size or number of
motor neuron end plates in target muscles of the hypoglossal
such as the glossohyoid (unpublished data). However, how then
does RegIII promote myelination in discrete populations of
motor neuron axons, and why is there such a restricted pattern
of RegIII expression?
Axons regulate Schwann cells during development of the
peripheral nervous system (29–33). The axon signals for regu-
lating Schwann cell differentiation are known to include both
proteins encoded by the neuregulin gene (NRG) signaling
through the erbB family of receptors, adhesion molecules such
as L1 and N-cadherin and neurotrophic factors such as brain-
derived neurotrophic factor (BDNF) (34–37). It has been sug-
gested that cell adhesion molecules on the axon surface as well
as signals from the extracellular matrix and neurotrophins are
also required for myelination to proceed efficiently and accu-
rately. For example, BDNF supports postnatal facial motor
neurones after axotomy and acts through p75 NTR to inhibit
Schwann cell migration and promote myelination (35, 36, 38). It
seems likely that RegIII released from subsets of motor neuron
axons is playing much the same role as BDNF in driving the
process of myelination. As with NRG1 type III, it has been shown
that RegIII signals through the PI3-kinase pathway (8, 17), and
this may represent a common pathway for axonally released
RegIII to influence Schwann cells. Why RegIII expression is
restricted to motor neurons concerned with the suckling and
swallowing is unclear, but we suggest that the patterning of this
Reg +/+ Reg -/-
N
um
be
r 
of
 a
xo
ns
40
30
20
10
0
My. Unmy.
Lateral Medial
Oculomotor nerve
***
BA C 
**
My. Unmy. My. Unmy.
Reg +/+
Reg -/-
P5
My.: myelinated
Unmy.: unmyelinated
Hypoglossal nerve
Fig. 6. Increased number of unmyelinated axons in RegIII KO mice. Electron micrograph of the medial hypoglossal nerve of RegIII wild-type (A) or RegIII
KO (B) mice. There is an increase in the number of unmyelinated fibers in the lateral and medial hypoglossal motor nerve of RegIIIKO mice (n 8 in each group).
(C) No differences were observed in the oculomotor nerve (n  3 in each group). The data show means  SEM. **, P  0.001; ***, P  0.0001. All nerves were
studied at P5. [Scale bar, 2 m (A and B).]
Tebar et al. PNAS  August 12, 2008  vol. 105  no. 32  11403
N
EU
RO
SC
IE
N
CE
critical function in neonatal mice may be plastic and regulated
by release of factors from target musculature concerned with
suckling in an activity-dependent fashion (8).
Materials and Methods
All procedures complied with the United Kingdom Animals (Scientific Proce-
dures) Act 1986.
Generation of the RegIII-Deficient Mice by Gene Targeting. The generation of
these mice has been described elsewhere (18). Complete knockout of the gene
was confirmed in nervous tissue with immunocytochemistry by using antibodies
generated against rat Reg2 protein, and absence ofRegIIImRNA was confirmed
by using real-time PCR in brain, pancreas, and regenerating liver (16, 18).
Real-Time RT-qPCR Assay. Tissue preparation and RNA extraction were as
described previously (39). RNA samples were treated with DNase I (Qiagen).
Equal amounts (3g) of total RNA were reversed transcribed by using random
nonamers (Sigma) and SuperScript TM III RT (Invitrogen) for 1 h at 50°C in a
total reaction volume of 20 l. cDNAs were immediately quantified by real-
time PCR or kept at 20°C until further experiments. Real-time PCRs were
performed with a DNA Engine (Bio-Rad) by using SYBR Green Jump Start
RT-PCR master mix (Sigma) with each gene-specific primer (RegIII forward,
5-AAGAATATACCCTCCGCACGC-3; RegIII reverse, 5-CAGACAT-
AGGGCAACTTCACC-3; RegIII forward, 5-GAAGTGCCCTCTCCACGTACC-3;
RegIII reverse, 5-ACAAATGGTAATGTCCCATCG-3; RegIII forward, 5-
GCTCCTATTGCTATGCCTTGTTTAG-3; RegIII reverse 5-CATGGAGGACAG-
GAAGGAAGC-3; -actin forward, 5-CAACGAGCGGTTCCGATG-3; -actin re-
verse, 5-GCCACAGGATTCCATACCCA-3). One microliter of cDNA was ampli-
fied in a three-step cycling program in a final reaction volume of 25l. Control
cDNA samples (obtained without transcriptase) were always included, as well
as samples without any cDNA template. Reactions were performed in tripli-
cate for five to six biological replicates, and threshold cycle values were
normalized to -actin gene expression. The specificity of the products was
determined by melting curve analysis. The ratio of the relative expression of
target genes to -actin was calculated by using the 2CT formula.
Facial Nerve Section. Pups were cooled on wet ice (4°C), and the extent of
anesthesia was determined by assessing reflex responses to tail pinch. Adult
mice were anesthetized with Fluothane. The right facial nerve was transected
at the stylomastoid foramen. One to 10 days later, mice were deeply anes-
thetized with Euthatal i.p. and transcardially perfused with 4% paraformal-
dehyde (PFA) in 0.1 M sodium phosphate buffer (PB) (pH 7.4) preceded by a
brief wash with heparinized saline. After a 2 h postfix in PFA, tissue was moved
to sucrose (30%) PB solution in preparation for freeze sectioning. In some
pups, 5l of CNTF (250 ng) applied to a piece of Gelfoam in 5l saline, or saline
alone, was applied to the cut end of the facial nerve at the time of section.
Animals received only one treatment: either CNTF or saline.
Detection of -Galactosidase Staining by X-Gal Staining. PFA-fixed tissue was
washed in PBT (PBS/0.1% Tween-20) several times. After a rinse in X-Gal
staining solution [5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6, 1 mM MgCl2, 0.01%
sodium deoxycholate, 0.02% Triton plus X-Gal (4-chloro,5-bromo,3-indolyl-
-galactosidase) at 1 mg/ml, suspended in PBS (pH 7.2)], tissue was transferred
to fresh staining solution. Tissue was incubated at 37°C in the dark overnight.
Sections were washed several times with PBT.
Cell Counting. Sections (40 m) were cut through the facial nucleus and all
sections (the facial nucleus is 700 m in length in the anterior–posterior
direction) were mounted and stained with neutral red. All neuronal profiles
in every section were counted and total counts corrected by using the Aber-
crombie correction (40).
Immunohistochemistry. Mice were deeply anesthetized with pentobarbitone
(60 mg/kg, i.p.) and transcardially perfused with 4% PFA in 0.1 M sodium
phosphate buffer (PB) (pH 7.4) preceded by a brief wash with heparinized
saline. Tissue was dissected and postfixed for 2 h at 4°C and then transferred
to 30% (wt/vol) sucrose in 0.1 M PB containing 0.02% (wt/vol) sodium azide.
40m free-floating tissue sections were processed as previously described but
for detection of RegIII (9, 39). Hypoglossal innervation of tongue muscula-
ture in wild-type and KO mice was assessed with PGP, a marker for nerve fibres,
and -bungarotoxin, a marker for muscle end plates.
ElectronMicroscopy.Mouse pups or adult mice (P21) were deeply anesthetized
with Nembutal and perfused with 10 ml heparinized saline followed by 20 ml
4% PFA plus 0.5% gluteraldehyde. Tissue was fixed overnight before dissec-
tion of the caudal tongue and attached hypoglossal nerves and the oculomo-
tor nerve still attached to the optic nerve and eyecup. After being osmicated
(30 min in 1% OsO4 in 0.1 M PB), the sections were stained for 15 min in 0.1%
uranyl acetate in sodium acetate buffer at 4°C, dehydrated in ethanols,
cleared in propylene oxide, and embedded in Araldite. Semithin sections were
cut with glass knives and stained with toluidine blue adjacent to thin sections
cut with a diamond knife on an Ultracut ultramicrotome (Reichert). The
sections were collected on mesh grids coated with a thin Formavar film,
counterstained with lead citrate, and viewed in a JEOL 1010 electron micro-
scope. Counts were made from four photographs of the lateral and medial
nerves for each animal taken at 4,000 magnification. Total counts of my-
elinated fibers at P21 were made from photomicrographs of the lateral and
medial hypoglossal nerves at 1,000 magnification.
Measurement of Milk/Colostrum Intake. The procedure described by Fujita and
colleagues (41, 42) was followed. Briefly, pups were separated from the dam
for 2 h and kept in a warm, dark chamber. The pups were then weighed and
placed back with the mothers for 1 h before reweighing. Thirty to 40 pups of
each genotype were used for the measurement of milk intake.
Statistical Analysis. The data are expressed as means  SEM. The data were
analyzed by general linear model univariate or multivariate test, as appropri-
ate, followed by Bonferroni post hoc tests or Student’s t test, as appropriate.
For all statistical analysis, statistical significance was set at P  0.05.
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